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Abstract 
Ni Zhao: Genetic regulation of sex-specific gene expression in mouse liver 
 
 (Under the direction of Ivan Rusyn, M.D., Ph.D.) 
 
Sexual dimorphism in the expression of many genes is thought to play an important role in 
disease susceptibility, drug metabolism, and xenobiotic response in both humans and other 
species. While previous research has explored the relationship between phenotypes and 
sex-dependent differences in expression of individual genes, this study dissected the 
genetic underpinnings that control sex-specific gene expression in mouse liver. We 
performed genetic mapping of genome-wide liver mRNA expression data in naïve male 
and female mice from C57BL/6J, DBA/2J, B6D2F1, and 37 BXD strains. Thousands of 
liver transcripts exhibited considerable differences in expression between females and 
males. An array permutation based functional analysis identified several xenobiotic 
metabolism pathways, which are strongly dependent on subject’s sex. Furthermore, 
expression quantitative trait locus (eQTL) mapping identified several eQTLs that are 
major sex-specific regulators of gene expression in mouse liver and the candidate genes 
that are likely to be the regulators for these loci were revealed. Co-expressed genes were 
shown to be more likely to be involved in similar functions, supporting the hypothesis of 
“guilt by association”. Conclusion: This study provided more evidence in the sexually 
dimorphic gene expression in the liver, which can convey important implications to 
toxicological and pharmaceutical studies. 
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 CHAPTER 1 
 
Literature Review 
  
Sexual dimorphic phenotypes in the liver  
Sexual dimorphism with respect to disease susceptibilities, drug metabolism and 
xenobiotic response are characteristics of many species, including humans. Liver is, arguably, 
the most metabolically active tissue and important for both pharmacology and toxicology and 
plays important role in defining the sex-specific differences. Metabolism of drugs and other 
chemicals in the liver may result in metabolic activation leading to either increased therapeutic 
effect (the statins, for example) or toxicity (acetaminophen, for example) in the liver or other 
organs. The physiological requirement for steroid hydroxylation differs between the sexes, and 
many enzymes in steroid metabolism, especially the cytochrome P450 superfamily, are 
expressed differently between males and females and this has long been known to have great 
biological implications (1; 2). For example, drugs metabolized by CYP3a family have long 
known to exhibit faster clearance in women than in men, although the clinical significance of this 
effect is yet to be confirmed (3). Furthermore, similar environmental exposure or diet can cause 
different effect to males and females because of their different metabolism in the liver. An 
anecdotal example includes alcohol induced liver injury, which is usually more severe in females 
than in males, with faster progression under similar alcohol consumption (4). The effect of the 
sexual dimorphic chemical metabolism is not limited to the liver, but influences other organs and 
the whole body as well. A mouse model has shown that carbon tetrachloride causes more severe 
 renal damage in male mice, an observation which was suggested to be associated with the 
reduction of the hepatic metabolizing capacity by CYP enzymes (5).  
For pharmaceutical companies, regulators and the general public, drug safety is a serious 
concern and drug induced liver injury is the primary reason that a prospective drug is pulled off 
from clinical trials (6). Women and men have different susceptibility when receiving similar 
dose of drugs. It is reported that women experience more hepatic adverse effect to treatment with 
therapeutic drugs than men, with 74% of drug induced acute liver failure to be in women (7) In a 
2002 report, women accounted for 79% of reactions due to acetaminophen and 73% of 
idiosyncratic drug reactions(8).  However, traditional liver diagnostic tests are not able to 
identify women at risk of acute liver failure before drug administration, but identification of this 
problem after drug approval can lead to removal of drugs from the market (7). Moreover, if this 
sex differences happen when patients are intentionally exposed to drugs, similar sex differences 
should exist when men and women are exposed to environmental xenobiotics. Understanding 
how the liver metabolism differs between males and females can be important in understanding 
these sex-dimorphic physiologies.  
With regard to baseline liver disease, women and men also show great difference in 
disease susceptibility, age of onset, or severity. Examples about sex dimorphic liver diseases 
abound in the literature.  For example, chronic liver diseases, including chronic hepatitis B, C 
and hepatic steatosis, progress more rapidly in males than in females (9). Cirrhosis, which is an 
important pathological process in liver carcinogenesis, is mainly a disease of men and 
postmenopausal women (10). The incidence of hepatocellular carcinoma (HCC), the most 
common liver cancer, is higher in males than in females with a male:female ratio of 2:1 to  4:1 
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 (11). The reasons for these sexually dimorphic phenotypes are still not completely understood 
and under constant exploration.  
Sexual dimorphism through hormones 
Many reasons have been proposed to be contributing to the hepatic sexual dimorphism. 
The most apparent and established reason is the sex hormone level that differs between males 
and females, beginning in utero and continuing throughout the life time of the organism (12; 13). 
Very few of the sex dimorphism can be apparent at birth, while most of the differences between 
sexes usually emerge at or after sexual maturation, when the sex hormone levels greatly differ 
between the two sexes. This indicates the role of sex hormones in regulating the sexual 
dimorphism. Two mechanisms have been proposed to explain the role of sex hormones in 
regulating sex specific phenotypes.  
Firstly, sex hormones can regulate gene expression by directly binding to estrogen 
receptor (ER) or androgen receptor (AR). Both ER and AR belong to a family of nuclear 
receptors and works in similar mechanism in gene transcription regulation. In the absence of 
hormone, ER and AR are largely located in the cytosol. Hormone binding to the receptor causes 
the moving of the receptors to the nucleus, as well as configuration change and dimerization of 
the receptor. The dimerized receptors can bind to specific sequences of DNA known as hormone 
response elements and recruit other proteins which are responsible for the transcription of 
downstream DNA.(14; 15).The genes regulated by ER and AR include several essential 
molecules in key cellular processes, including immune responses, steroid metabolism, cell 
proliferation and apoptosis. The structure and function of ER and AR were best studied in 
cancers of reproductive tissues as well as in somatic tissues, such as liver (16-18). 
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 The second mechanism by which the sex hormone affects gene expression is through sex 
specific secretion pattern of growth hormone (GH). GH is a pituitary protein hormone that 
regulates a broad range of physiological processes, including long bone growth, fatty acid 
oxidation, glucose uptake, and hepatic steroid and foreign compound metabolism. The sex 
specific secretion pattern of GH is most apparent in rat, where adult males secret GH in a 
pulsative manner, with about 2 hours low serum GH intervals while the females secret GH in a 
more frequent manner, resulting a constant blood level of GH. Similar patterns also exist for 
mice and humans, but to a smaller extend. These adult patterns of GH release are set during the 
neonatal period by exposure to gonadal steroids, which program the hypothalamus and its 
regulation of pituitary GH secretion at the onset of puberty and during adulthood (19).  A major 
difference between male and female GH profiles is the GH free intervals between secretion 
pulses in males. The GH free interval is essential in the expression of a lot of male specific 
enzymes, including cytochrome P450 2C11 (CYP 2C11) (20). In the liver, the sex specific GH 
secretion activates intracellular signaling pathways to the sexually dimorphic transcription of 
CYPs and other liver-expressed genes.  
Sexual dimorphism through gene regulation  
The contribution of genes on sex chromosomes to human diseases and animal traits has 
long been appreciated. It is known for a long time that men and women have different sex 
chromosomes, with two X chromosomes in females and one X chromosome and one Y 
chromosome in males. The Y chromosome harbors very few genes, most of which are expressed 
only in testes. The other genes in Y chromosome are usually “house-keeping genes”, which are 
essential in all tissues and conditions and expressed in a constant amount. These genes usually 
have X chromosome homologues that escape X inactivation (21). The X inactivation process 
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 ensures that men and women share similar expression level for most of the X linked genes 
despite the different amount of DNA dosage. However, when there are genetic defect in some 
essential X chromosome genes, the X-inactivation pattern in females can be skewed in most 
cases in favor of the normal gene expression, which account for some of the sexually dimorphic 
diseases (22). For example, X-linked recessive diseases are mostly expressed in males: female 
carriers of X-linked recessive mutations often exhibit skewed X-inactivation pattern to produce 
normal gene expression and have healthy phenotypes (22). Anecdotal examples of these diseases 
include red-green color blindness, hemophilia, the Duchenne and Becker forms of muscular 
dystrophy (both of which involve mutations in the DMD gene) and the glycogen-storage disease. 
More generally, if this skewed X-inactivation can be responsible for the X-linked diseases, 
similar mechanism would be also possible contributors to other common diseases and 
phenotypes, in which X chromosomes genes are involved to a certain extent.  
In contrast to sex chromosomes, the autosomal genomes are shared between males and 
females with common DNA sequences, gene structure and similar frequency of polymorphisms 
between males and females. The mechanism of how the autosomal genomes contribute to sex 
specific traits was not understood as clearly as the effect of sex chromosomes. The autosomal 
genomes were assumed to be similar between men and women until very recently. However, 
evidence is accumulating that natural variation within the autosomal genomes of many species 
also affect the physiological traits differing between males and females. Sex specific gene 
expression and regulation, other than DNA content, may underlie most phenotypic differences 
between males and females.  
At the mRNA level, sexually dimorphic gene expression has been observed for many 
species in autosomal tissues, including flies (23), worms (24), fish (25), rodents (26) and 
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 primates (27). For example, the sexual dimorphism in the regulation of oxidative stress response 
could potentially differentially affect the susceptibility of cardiovascular disease in males and 
females (19). A lot of these sexually dimorphic genes are essential in metabolism of steroid, 
drugs and other environmental chemicals. Examples include several cytochrome P450s, which 
are essential in drug and steroid metabolism (28-31). The observation of the sex specific gene 
expression pattern suggested that at least a part of the sexual dimorphism is attributable to the 
sex specific gene expression pattern. Some other studies have indicated that the sex specific gene 
expression is also tissue specific, whereby the genes differentially expressed in males and 
females in some tissues may not be sexually dimorphic in other tissues (32).  
BXD Recombinant Inbred Mice 
Mouse is the most used animal model in studying the effect of genetic background on 
gene expression. One benefit of using mouse models in genetic studies is that the genotypes of 
the mice can be controlled. Inbred strains are used in lab experiments for almost 100 years and 
its values in genetics are well established and appreciated. Inbred strains can be created by 
sibling mating for over 20 generations, leading to increased homozygosity in at least 99% of the 
genome. In this way, inbred strains are homozygous at all genomic loci and each strain has 
identical genotypes (33). When exposed to similar environmental toxicants or pharmaceuticals, 
mice of the same inbred strain would respond similarly. The decreased genetic diversity and 
phenotypic variance within an inbred strain can reduce the number of animals needed to detect 
statistical significance. Also the reduced phenotypic variation within each strain is invaluable for 
reproducing phenotypic measurement in different lab laboratories. Furthermore, a lot of the 
inbred strains have been sequenced or have extensive high density single nucleotide 
polymorphism (SNP) maps, which is essential in understanding the genetic regulation.  
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 The human population is genetically and physiologically diverse: when people are 
exposed to similar environmental toxicants or other exposures, some of them may suffer no 
measurable injury while some people might experience severe damage. Each individual has 
different genotype, except for identical twins. Single inbred strains are not sufficient to 
understand the genetically diverse human population. Recombinant inbred (RI) strains are a 
special type of inbred strains, which are created in such a way that its genome is a permutation of 
the genomes of progenitor inbred mouse strains. BXD RI mice are created by mating two inbred 
strains C57B6J and DBA to get the F1 generation. Then the F1 generations are sibling mated to 
produce the F2 generation. The continuation of the sibling-mating process for more than 20 
generations produced inbred lines in which the majority of the mouse genome is isogenic. Within 
each strain, every individual has identical autosomal chromosomes, while the panel of inbred 
mice can exhibit great differences in both genotypes and phenotypes. The C57B6J and DBA 
mice have been known to show great differences with regard to some important hepatic 
phenotypes. The BXD mice panel has been a useful tool in studies on certain disorders, including 
alcohol preference and tolerance (34), alcohol metabolism (35), responsiveness to aromatic 
hydrocarbons (36), N,N-diethylnitrosamine induced hepatocarcinogenesis (37) and diabetes and 
atherosclerosis (38; 39). The RI strains have a known ancestry and a controlled mixture of 
genomes while remain the homozygosity and reduced intrastrain phenotypic variance of inbred 
strains. It should be noted that, although individuals in each inbred strain have identical genome, 
different strains can exhibit extensive phenotypic differences and genetic differences, in 
accordance with genetically diverse human population. Studies on the RI strains can help 
understanding how the genetically diverse human population responds to different exposures.  
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 Systematic evaluation of the sex specific gene expression in mice 
The advance of gene expression technology has made possible to systematically evaluate 
the sex specific gene expression and explore how the natural variation within the autosomal 
genomes can affect the sex specific gene expression (40-42).  Current microarray technology 
allows for the measurement of thousands of genes’ expression simultaneously, with a reduced 
cost of time and money. The sequencing of entire mammalian genomes provided an 
unprecedented amount of genomic information, which can be combined with high throughput 
gene expression data to assess the effect of genetics on constitutive levels of gene expression(41-
43). Quantitative Trait Locus (QTL) mapping can be used to associate a specific genotype with a 
phenotypic measurement like high density lipoproteins (44) and ethanol tolerance (45). When 
mRNA transcription, collected using microarray analysis, are considered to be quantitative 
phenotypes, similar QTL mapping strategy can be applied to uncover how the genetic 
background regulate the expression of genes.  
From a whole genome prospective, five studies have investigated the sexually dimorphic 
gene expression in mouse liver (32; 46-49), two of which addressed the question of whether the 
GH regulate the sexually dimorphic gene expression (46; 47). A brief review of these studies will 
be helpful to our understanding of the genetic reasons for sexual dimorphism in mouse liver.  
Amador-Noguez et al (47) used gene expression profiling to determine the sex-specific 
and sex-independent changes in the liver of Ames dwarf mice compared with their wild-type 
litter mates. Ames dwarf mice are homozygous with a loss of function mutation in the Prop1 
gene, which can cause defect embryonic development of anterior pituitary gland and lead to life-
long deficiencies in GH, prolactin, insulin like growth factor, and thyroid stimulating hormone 
secretion (50; 51). Out of the 14,000 genes mapped to the microarray, 123 were discovered as 
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 significantly differently expressed between two sexes in wild-type mice with p values less than 
0.001. In contrast, the sexually dimorphic gene expression pattern is nearly completely lost in the 
Ames dwarf mice, with only 7 genes differently expressed in two sexes. The fact that Prop1 
mutation produced a nearly complete loss of sexual dimorphism in gene expression indicates that 
pituitary gland hormones are a major contributor to the sex specific gene expression. In a study 
by Clodfelter et al (52), large scale gene expression profiling was used to evaluate the expression 
in wild type and Stat5b inactivated mice and(53) to characterize sex differences in liver gene 
expression and their dependence on Stat5b. STAT (signal transducer and activator of 
transcription) proteins are transcription factors which respond to a variety of extracellular 
cytokine and growth factor signals, especially growth hormone (54-56). At a fold change 
threshold of 1.5, 1603 genes were identified with sex biased expression in wild type mice. Of the 
850 genes which showed higher expression in males, 90% were down-regulated in Stat5b 
deficient males. Similarly, out of the 753 genes with higher expression in females, 61% was 
upregulated in Stat5b deficient males. However, 90% of the sex biased genes in females were not 
affected by Stat5b deficiency. These findings suggested that Stat5b is essential in the expression 
of male-predominant genes. A following study (46) by the same group investigated the 
dependence of sex specific liver gene expression on STAT5a. STAT5a is another isoform of 
STAT5, which shares 90% identical amino acid sequence to STAT5b and also responds to 
sexually dimorphic plasma GH stimulation. 1437 genes were discovered as female biased in wild 
type mice, within which 219 (15%) had decreased expression in STAT5a-deficient females. In 
contrast, in the 1045 male biased genes, only 56 had significantly increased expression in Stat5a 
knock out females, the effect of which is trivial. These two studies, together, provided evidence 
of the importance of STAT on the regulation of sex-specific gene expression, with STAT5a more 
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 significant in female livers while STAT5b more important in male livers.  Because both STAT5a 
and STAT5b are transcription factors involved in GH signaling pathway, these results confirmed 
the important role of GH in regulating the sexually dimorphic gene expression.  
 The other two studies (32; 49) differ from the previous three by, instead of assessing the 
sexually dimorphic genes in a single strain, evaluating the gene expression differences in several 
strains. Yang et al (32) analyzed the gene expression from 334 mice derived from an intercross 
between inbred mouse strains C57BL/6J and C3H/HeJ in multiple tissues, including the liver. 
All strains used were apolipoprotein E (apoE) knockout mice that were sacrificed at 6 months of 
age after being fed a Western diet for 4 months. 9250 (72%) genes were detected as sexually 
dimorphic in the liver, indicating the widespread sexual dimorphism in hepatic gene expression. 
But when the extent of sexually dimorphism was considered, most of these sexually dimorphic 
genes displayed <1.2 fold change in one sex versus the other. These sexually dimorphic genes in 
the liver are enriched for protease inhibitor activity, immune/defense response, carboxylic acid, 
fatty acid, steroid and lipid metabolic pathways, electron transport, monooxygenase activity, and 
oxidoreductase activity. Moreover, the eQTL hotspots for subsets of the sexually dimorphic 
genes provided evidence of the genetic regulation of gene expression. The use of the apoE 
knockout mice and the high fat diet was related to a sex biasd trait---atherosclerosis. Although 
the authors could not rule out the influence of the particular genetic background or the effect of 
diet on sexually dimorphic gene expression, the large number of animals provided the power to 
detect the small differences in gene expression between sexes and the intercross mouse genome 
allowed the analysis of genetic control of sexually dimorphic gene expression. 
The very recent study, Su et al used a customer designed microarray to evaluate the sex 
and strain effect on gene expression and exon expression in the liver of three mouse strains - 
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 DBA/2J, C57BL/6J and C3H/HeJ. Gene expression was assessed using two methods: 3' gene 
expression profiling and whole-transcript gene expression profiling. Exon expression was 
determined using exon probes and flanking junction probes that spanned across the neighboring 
exons. The exon expression was reflective of not only the mRNA transcription, but also 
alternative splicing. 32% of the genes have sex biased expression in at least one of its exons 
while only 17% of the genes were detected as sex biased using 3’ gene expression profiling 
(Bonferroni corrected p-value < 0.01). Over 90% of the genes that were identified as sexually 
dimorphic via either whole gene expression profiling were also identified as sexually dimorphic 
via exon profiling. On the other hand, 38% of the genes identified as sexually dimorphic using 
exon profiling cannot be identified via either 3’ gene profiling or whole gene profiling.  The fact 
that exon profiling identifies more differences indicated that sex also influence the alternative 
splicing process as well as gene transcription, providing suggestions for further studies.  
Missing from the current literature is a study of constitutive gene expression in the 
sexually dimorphic gene expression in mouse liver using a panel of RI strains. This kind of study 
would be revealing to why men and women respond differently to similar environmental and 
pharmaceutical exposures. Also it would help us understand how small changes in a cluster of 
functionally related genes can have significant effect on physiology.  
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 CHAPTER 2 
Introduction 
 
Despite having nearly identical genomes, males and females have been shown to differ in 
gene expression, disease susceptibility, drug metabolism, and xenobiotic response (4; 57). The 
liver is a key organ for defining sex-specific differences in steroid and xenobiotic metabolism, as 
well as complex physiology and function of other tissues (58). Much is known about the genetic 
and transcriptional regulatory mechanisms that control sex-specific differences in response to 
certain xenobiotics in the liver (32; 59-61). Evidence is sparse, however, regarding the extent of 
the global differences in gene expression networks that may exist between males and females 
under normal physiological conditions (62). 
Gene expression quantitative trait locus (eQTL) mapping is a statistical approach used for 
comparing mRNA levels, collected using microarray analysis, with genetic polymorphisms 
segregating in a population to discover genomic intervals that are likely to regulate the 
expression of each gene (63). This approach has been used successfully to identify co-regulated 
genes, to discover genes potentially regulating the expression networks, and to understand 
normal tissue-specific physiology and underlying disease-related phenotypes (40-42; 64; 65). 
Successful validation of a trans-eQTL hotspot relating to oxidative phosphorylation in mouse 
adipose tissue was recently reported (66), thus underscoring the validity of this computational 
approach for identification of key networks that may be genetically controlled.  
With regards to the liver, the sex-independent polymorphic local and distant QTLs, 
including several loci that control the expression of large numbers of genes, were also identified 
 by comparing the physical transcript position with the location of the controlling QTL (67). Still, 
it is not known whether sexual dimorphism exists in genetic regulation of liver gene expression 
networks. To address this gap in our knowledge, we used gene expression data from livers of 
naive mice from C57BL/6J, DBA/2J, B6D2F1, and 37 BXD strains to understand the variation 
in gene expression between males and females. Genes that were differently expressed between 
sexes were selected and assessed. Pathway analysis was carried out using an array permutation 
approach to uncover the biological pathways exhibiting strong sexual dimorphism. eQTL 
mapping and transcriptome maps of both male and female liver gene expression were compared 
to discover the similarities and differences in regulatory networks.  
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 CHAPTER 3 
Materials and Methods 
 
Gene Expression Data 
The details on mouse breeding, housing, RNA isolation and gene expression are 
described elsewhere (67). Tissue collection was conducted at the University of Tennessee at 
Memphis and approved by the Institutional Animal Care and Use Committee at UT-Memphis. 
Briefly, 37 strains of male BXD RI mice, C57BL/6J and DBA/2J parentals, and B6D2F1 were 
used to perform genome-wide eQTL mapping for 20,868 transcripts using Agilent (Santa Clara, 
CA) G4121A microarrays. RNA was pooled from 2-3 mice of the same sex and strain for each 
microarray and each strain has only one microarray for each sex. Gene expression data is 
available from www.genenetwork.org.   
Statistical Analysis of Gene Expression Data 
A Student’s t-test with a Bonferroni correction (α = 0.01) was used to select genes that 
are differentially expressed between females and males.  These genes were grouped by fold-
change (>1.2, >1.5, >2, and >3) differences between sexes using the median log2 transformed 
expression value in each sex. A two-step permutation based method (68) Significance Analysis 
of Function and Expression (SAFE) was used to identify the significant functional relationships 
among differentially expressed genes using the Gene Ontology (GO) and Kyoto Encyclopedia of 
Genes and Genomes  (KEGG) using a graphical interface SAFEGui v1.0 (69). SAFE settings 
were as follows: the Student’s t-test was chosen as local statistic, the Wilcoxon Rank Sum test as 
global statistics. Benjamini and Hochberg false-discovery rate (FDR) was determined under 
 5000 permutations. The graphical algorithm of Voy et al (70) was utilized to assess gene 
correlation. A gene expression “clique” was defined as a cluster of genes in which every gene 
pair has an absolute Pearson correlation coefficient above 0.9.  
eQTL Mapping  
QTL linkage mapping was carried out using QTLReaper (71) which performed 1000 
permutations of the strain labels to obtain genome wide p-values (72). Interval mapping was 
performed in a web-based tool WebQTL (73). The details of the markers, QTL identification and 
WebQTL were reported elsewhere (67). Microarray probes were mapped to the mouse genome 
(NCBI Build 36) and SNPs overlapping the probes were sought using data from Szatkiewicz et 
al. (74). The proportion of SNPs overlapping probes for cis-QTLs was compared with that in 
trans-QTLs using a χ2 test to determine the potential bias. Transcriptome maps for both sexes 
were produced in R [ver. 2.7, (75)] by relating transcripts location to their maximum LRS 
location on the genome at FDR<=0.25, using the QTL data from QTLReaper. Histograms were 
generated by counting the number of transcripts mapped to each genomic location within 1 Mb 
window. Genomic regions that are identical by descent (IBD) between C57BL/6J and DBA/2J 
were inferred by searching for 100 consecutive SNPs with identical allele calls in both parental 
strains using the web tool [http://compgen.unc.edu/DisplayIntervals/DisplayIntervals.html; (76)].  
The IBD regions between C57BL/6J and DBA/2J were excluded from the analysis to narrow 
eQTL windows.  
Transcription Factor Binding Site (TFBS) Enrichment 
The oPPOSUM (77) tool was used to assess the TFBS enrichment in the differentially 
expressed genes of each sex for Single Site Analysis (78). For each transcript, the top 10% of 
conserved region in the 5000 bp upstream/downstream sequences between mouse and humans 
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 with minimum conservation of 70% and matrix match threshold of 80% was scanned for TFBS 
in the JASPAR database using a position weight matrices algorithm.   
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 CHAPTER 4 
Results 
 
Characterization of sexually dimorphic liver genes in BXD mouse panel 
Genes that are differentially expressed in female and male livers were selected using a 
student’s t-test and a Bonferroni correction (α = 0.01). Out of the 20,868 transcripts on the array, 
1,534 genes were found to be sexually dimorphic. Specifically, 639 genes had significantly 
higher expression in females (female-biased genes) and 895 in males (male-biased genes). Table 
1 summarizes the distribution of sexually dimorphic genes, at different fold-change level. The 
majority of sexually dimorphic genes (72.6% in females and 84.9% in males) are less than 1.5-
fold different between sexes.  
To determine whether the differences could be attributed to control by transcription 
factor(s), binding site enrichment was evaluated in the conserved sequences within 5,000-bp 
upstream and downstream regions of the sexually dimorphic genes. The sexually dimorphic 
genes (1,534 genes) showed significant enrichment for the binding site for HNF4A. The female-
biased genes (639 genes) showed enrichment for the binding site for HNF1A, IRF2 and NR2F1; 
however, the male-biased genes (895 genes) didn’t exhibit evidence for transcription factor 
binding. Androgen binding site was not discovered as significant TFBS in the sex biased genes 
(Fishers exact p = 0.379) and estrogen binding site is not quarried by oPOSSUM tool. 
SAFE (68) software was used to determine biological categories and pathways associated 
with sexually dimorphism in gene expression. Using an array permutation approach, SAFE takes 
into account unknown correlations between genes in functional categories. After accounting for 
 multiple comparisons, none of the Gene Ontology pathways were shown to be significant at false 
discovery rate 0.25. Nine KEGG pathways were significantly different in males and females at 
FDR 0.05 (Table 2) and 59 KEGG pathways were significant at FDR 0.25.  
Genetic regulation of sexually dimorphic genes in mouse liver 
To investigate possible genetic control of sex differences in gene expression regulatory 
networks, interval mapping was independently performed in each sex. A transcript which has a 
QTL less than 5 Mb away from its own genomic location was considered to be a cis-QTL (79; 
80), implying a possible controlling mechanism near the gene itself, although the mere existence 
of cis-QTL is not sufficient to draw firm conclusions on the regulation mechanism. QTLs which 
are more than 5 Mb away from their controlled transcripts were considered as trans-QTLs. When 
a transcript showed the same maximum QTL location in both sexes, this QTL was identified as a 
shared QTL. It has been suggested that, since C57BL/6J sequence is used for array probe design, 
spurious eQTLs may be detected in genetic crosses due to SNPs in probes (79; 81). We found 
that no bias exists in our data (data not shown).  
The distribution of eQTL in both sexes is summarized at Table 3. It is interesting that cis-
eQTLs are more robust than trans-eQTLs whereby more cis-eQTLs were shared between 
females and males. In addition, more cis-eQTLs remained significant with increased stringency 
(FDR threshold) while the number of trans-QTLs diminished rapidly.   
In both female and male datasets there are genomic loci that appear to regulate a larger 
number of genes than expected by chance. The, so called, eQTL hotspots are SNPs that are 
associated with expression differences in ten or more transcripts (Table 4). The cutoff was 
selected based on the 95 percentile of the binomial distribution with n=20,868 (the number of 
transcripts analyzed) and probability = 1/3,795 (the number of SNP markers).  
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 Sex-specific transcriptome maps for liver gene expression in mice were generated by 
plotting location of each transcript with an eQTL against the location of its respective peak 
eQTL location (Figures 1A and B). Histograms were generated by counting the number of 
transcripts mapped to each genomic locus within 1 Mb window (Figures 1 C and D).  
In addition to sex-independent strong “master-regulator” trans-eQTL that has been 
reported to exist in mouse liver (67; 82), there are several sex-specific eQTLs that control 
expression of dozens of liver genes (Figures 1C and D). To identify the potential regulatory 
genes in the QTL transbands, we first narrowed the QTL regions by eliminating regions that are 
identical-by-descent between C57BL/6J and DBA/2J mice. High density SNP maps 
encompassing 7.87 million polymorphic loci across these strains show that about 43.7% of the 
genome is shared between C57BL/6J and DBA/2J strains, which is in agreement with the 
breeding history (83). Regions that are not identical-by-descent were further explored for 
presence of sex-specific “master-regulator” genes (Figure 2A and B). Candidate genes were 
selected using the following criteria: 1) it should be locally regulated or contain non-synonymous 
coding SNPs between C57BL/6J and DBA/2J mice; 2) it is expressed in the liver. Naps1, 
Ceacam9 and Grlf1 are candidate regulatory genes that may be responsible for the male-specific 
chromosome 7 eQTL hotspot (Figure 2B); however, no annotated genes were identified in the 
strongest female QTL hotspot on chromosome 6 (Figure 2A).  
Gene Correlation exhibits distinct patterns from gene expression between the sexes. 
Co-regulated genes are more likely to be co-expressed and correlation matrix network 
analysis has been proposed for discovery of genes that form “cliques” (70).  We applied this 
approach to liver gene expression data from male and female mice separately. Gene pairs with 
absolute Pearson correlation coefficient greater than 0.90 were selected to construct edge-
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 weighted graphs of the cliques. The top 30 genes appearing in the largest number of cliques were 
defined as clique enriched genes.  There was little overlap between clique-enriched genes and 
genes that are differentially expressed between sexes (data not shown). For example, only nine of 
the top 30 male clique-enriched genes also exhibited higher expression in males, while none of 
the top 30 female clique-enriched genes had significantly higher expression in females.  
To visualize clique-enriched genes, a correlation matrix (Figure 3A and D) and a gene 
expression heat map (Figures 3B and E) were constructed using unsupervised two dimensional 
clustering analysis of the 579 female and 625 male transcripts which are involved in at least one 
clique. Interestingly, highly correlating genes show distinct patterns in expression between 
strains (red and blue bars for sub-clusters) whereby some clusters (blue bars) are clearly sex-
specific, while others (red bars) are not. With regards to sex-specific co-correlating genes, there 
were 76 in females and 151 in males and 60 of those were shared between these clusters.  
In addition, when eQTL locations for all co-correlating genes were plotted (Figures 3C 
and F) it became evident that highly correlated transcripts, represented by cliques, are more 
likely to be regulated by similar eQTL loci. For example, 75 (49.6%) of the 151 male-specific 
co-correlated transcripts, which varied in expression between sexes (blue bars), share an eQTL at 
chromosome 5 (58.9 Mb to 71.0 Mb) and are highly inter-connected in a “molecular transport” 
ingenuity-derived network (Figure 4B). Similarly, 49 (64.5%) of the 76 females-specific genes 
have their eQTLs clustered on distal chromosome 5 (136.5 Mb to 144. 7 Mb). The top network 
for the female genes was “cell-cell signaling and interaction” (Figure 4A).  
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CHAPTER 5 
Discussion 
 
 
Sex-dependent differences in gene expression in the liver: physiological and toxicological 
significance 
In this study, we studied the magnitude and possible regulation of sex-dependent 
differences in gene expression in liver using a panel of BXD recombinant strains. While several 
reports have examined sexual dimorphism in liver gene expression in the mouse, our work has 
used a genetically-defined population (84) to address this issue on a more comprehensive level 
and to determine whether potential genetic regulators can be identified.  
Indeed, thousands of genes were identified as significantly differentially expressed 
between males and females in the 41 strains at different fold change levels with many of the 
previously reported genes also confirmed by our study. A recent review article (62) provides a 
summary of four earlier studies in mouse liver (32; 46-48) and identifies  48 genes as being at 
least two-fold higher expressed in females than in males in at least two studies. Of these, 26 
genes show a comparable magnitude of female-biased expression in our study (Table 5A). 
Similarly, 15 of 54 males-biased genes selected using the same criteria were confirmed in our 
work (Table 5B). Since previous studies were conducted using varying experimental designs 
(different strains, diet, age, and physiological conditions), a wide variety of microarray platforms 
and statistical stringency criteria, we consider this high (28 and 54%) degree of replication to be 
 biologically significant as the genes that replicate between multiple studies are highly robust 
representatives of sex-specific expression differences.  
Two previous studies (32; 49) assessed sex-specific differences in liver gene expression 
using more than one strains of mice and reported a list of sexually dimorphic genes at 
comparable threshold cutoffs. The magnitude of sexual dimorphism in liver transcriptome (7.4% 
transcripts showing the effect of sex) in our study is smaller than reported previously. For 
example, Su and co-workers (49) reported that about 17% genes are sexually dimorphic in three 
mouse strains – DBA/2J, C57BL/6J and C3H/HeJ. Yang et al (32) concluded that as many as 
72.0% (9250 of 12,845) of the genes are sex-biased in an F2 cross between C3H/HeJ and 
C57BL/6J. While the exact reason for the differences between our and other studies is difficult to 
determine, both statistical methods and study design factors are most likely contributors. First, 
Su et al (49) reasoned that a very high percentage of sexually dimorphic genes in their study 
could be due to the number of animals assessed per sex per strain in different studies. Second, 
when our data was re-analyzed using the criteria detailed by Yang et al (32) (i.e., Q value=0.2%), 
a larger proportion of genes (17.2%) 3597 genes was found to be sexually dimorphic, a finding 
confirming the use of Bonferroni correction in our work to establish a more robust representation 
of sexual dimorphism in gene expression.  
The sexually dimorphic expression of many drug metabolism and other liver-expressed 
genes has been suggested to be regulated, to a large degree, by the temporal pattern of plasma 
growth hormone release by the pituitary gland, which shows significant sex differences. These 
differences are most pronounced in rodents, where plasma growth hormone profiles are highly 
pulsatile in males but are nearly continuous in females. The growth hormone–Stat5b pathway 
was shown to be one of the key regulators of sexual dimorphism in mouse liver gene expression. 
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 Hepatocyte nuclear factor 4a (HNF4a) is an important transcription factor in response to sexually 
dimorphic growth hormone secretion pattern responsible for up-regulation of males-biased genes 
(60; 85). Indeed, our study showed that HNF4a binding site was significantly enriched in 
sexually dimorphic genes, consistent with the biological roles of HNF4a and growth hormone.  
Consistent with previous reports, the reproducible sexually dimorphic genes detected in 
this study are essential for lipid metabolism, xenobiotic response and hormone metabolism 
(Table 2). For example, Gstp1 is a male-biased gene which encodes a key glutathione S-
transferase enzyme. In humans, GSTpi plays an important role in the detoxification of many 
hydrophobic and electrophilic compounds and is a biomarker of the overall survival in cancer 
patients (86). In the mouse, even though the baseline expression of Gstp1 is much higher in male 
liver, its expression is suppressed in males, but elevated in females in pre-neoplastic liver lesions 
(87). Flavin-containing monooxygenase 3 (Fmo3), on the other hand, is a prominent female-
biased gene in the mouse liver, but in humans Fmo3 is expressed in livers of both sexes (88; 89). 
Fmo3 has affinity for numerous substrates, including nicotine, tertiary amines, drugs, carbamates 
and organophosphates (90).  This suggests that sex differences in Fmo3 expression should be 
acknowledged in mouse toxicity studies in which Fmo3 is the enzyme responsible for 
metabolism of the xenobiotic under investigation.   
Genetic component of the sex specific gene regulation networks: eQTL analysis 
It is likely that sex-specific hepatic gene expression has a complex mode of regulation 
with mechanisms other than growth and sex hormones being involved. The sex-specific eQTL 
hotspots discovered in our study provides evidence for the genetic component that may be also 
important. Previously, Yang et al. (32) assessed whether genetic variation can regulate sexually 
dimorphic gene expression by using eQTL analysis. We utilized a different strategy by searching 
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 for QTLs in males and females separately. Four loci were identified to be regulatory hotspots in 
both males and females, including the strongest regulatory loci in chromosome 12. Six loci were 
found to be regulatory in females specifically and another five distinct loci were discovered in 
males.  
We report that a locus on chromosome 7 is a most significant male-specific eQTL hotspot. 
Naps1, Ceacam9 and Grlf1, are located in this location and are possible quantitative trait genes. 
Npas1 (neuronal PAS domain protein 1) encodes a basic helix-loop-helix transcription factor 
which inhibits gene transcription (91), and is a reasonable candidate for regulation of gene 
expression. In adult mice Npas1 is only expressed in specific regions of the brain and Npas1 
negatively regulates the expression of erythropoietin and promotes neuronal progenitors in the 
nervous system (92). In vivo, Npas1-knockout mice exhibit behavior deficiency, including 
diminished startle response, as measured by prepulse inhibition, and impaired social recognition 
(93). In mouse embryos, Npas1 has been found in a variety of tissues including liver and the 
Npas1 protein was suggested to be stable and abundant in the liver, despite relatively low mRNA 
levels (94). The possibility exists that the embryonic liver gene expression causes long term 
effects in regulating the expression of other genes. It is also possible that the Npas1 protein 
persists in the liver, as a transcription factor through adulthood. In humans, NPAS1 was mapped 
to chromosome 19q13.2-q13.3, a syntenic region to the region in mouse chromosome 7 
containing Npas1, indicating that the mouse and human genes are true homologs (95). Ceacam9 
(carcinoembryonic antigen-related cell adhesion molecule 9) is a member of a family of 
glycoproteins containing immunoglobulin domains (96). .  However, its function is poorly 
understood and knockout mice developed no observed abnormalities during development. Grlf1 
(glucocorticoid receptor DNA binding factor 1, p190A) encodes a Ras GAP-binding 
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 phosphoprotein which regulates the actin cytoskeleton and has important function in cell 
adhesion, migration and polarity (97). The encoded protein can associate with the promoter 
region of the glucocorticoid receptor gene and suppress glucocorticoid receptor transcription. In 
human cancer cell lines, Grlf1 expression is regulated by glucocorticoids may act as a human 
tumor repressor gene (98).  
While the strongest eQTL liver locus in both sexes is on chromosome 12 (82), the 
strongest male-specific eQTL transband is on chromosome 7 and regulates the expression of 55 
genes.  The strongest female-specific eQTL transband is on chromosome 6 and it regulates only 
about half that many transcripts (26 genes). It is possible that a much weaker female bias in 
genetic regulation of gene expression is due to the lack of synchronization of the estrous cycle in 
our study; thus, a study assessing the influence of estrus cycle on the global gene expression or 
one using synchronized females may minimize this potential bias.  
Co-correlation analysis reveals sex-specific gene expression networks 
The correlation analysis revealed that gene co-expression networks may be used as a tool 
to uncover the connectivity between gene function and gene regulation. The fact that highly 
correlated genes are involved in similar functions supported the assumption of “guilt-by-
association” (99). The graphical algorithm (70) used here allows for the assignment of each gene 
into different connected clusters, consistent with the biological context whereby genes may play 
important roles in multiple distinct pathways. Also, unlike other methods, this analysis doesn’t 
seem to be plagued with false positives because of the stringent criteria to form cliques. However 
several limitations do exist in this analysis: because cliques represent the perfectly correlated 
gene clusters and the selection of cliques relies on an edge meeting a high threshold (correlation 
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 coefficient of 0.9), it can exclude the edges which fall short of the selection threshold. This might 
impede biologically interpretation of the gene-gene relationships.  
 
In conclusion, this study assessed the hepatic gene expression network between two 
sexes in a BXD RI mice population. Unlike studies carried in only one strain, the genetic 
diversity in the BXD population would shed light on the global sexually dimorphic gene 
expression in a human population with similar genetic and phenotypic diversity. The well studied 
inbred mouse genome provides gene and function annotations which allow us to generate 
testable hypothesis with regard to gene regulation network. Also our findings have several 
implications for toxicology and pharmaceutical studies. Not only the few genes that show 
significant sex differences are important in assessing toxic responses in males and females, a 
large number of functionally related genes with small differences between sexes could also 
contribute to many sex biased phenotypes. Cautions should be taken when applying the results 
from a study which were carried out in only male objects (which is very common in 
toxicological studies) to the whole population. Finally, the sexually dimorphic gene expression, 
at least partly, is due to the genetic reasons. Other genomic information, like genome structure 
similarities and IBD regions, when combined with eQTL mapping, can facilitate the process in 
finding candidate regulatory genes.  
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 CHAPTER 6 
Study Limitations and Further Direction 
 
This study does have some limitations and further research would be needed to better 
elucidate the mechanism of sexually dimorphic gene expression pattern and how these results 
can be applied in human risk assessment.  
First of all, the way the data was generated in this current study doesn’t allow for the 
assessment of sex-strain interaction with regard to gene expression regulation. In this study, 
RNA from 2-3 mice of the same sex and strain was pooled in a single microarray plate to get the 
gene expression. This pooling procedure has the benefit in smoothing the gene expression 
variation in different individuals within the same strain and eliminating possible outliers. 
However, only one microarray data point was generated per sex per strain, therefore the effect of 
sex and strain interaction on gene expression cannot be analyzed. The study can only provide 
preliminary insight and testable hypotheses about the genes responsible for gene expression 
regulation. On the other hand, one recent study conducted on DBA, C57B/6J and C3H/HeJ 
mouse strains has indicated that the sex differences are larger than strain differences in gene 
expression (49), suggesting the importance of testing the sexually dimorphic gene expression in 
understanding liver biology even without the analysis of sex-strain interaction. 
Secondly, the regulation of sex specific gene expression is very complex, with a lot of 
mechanisms contributing. The result of the genetic regulation of gene expression cannot be 
conclusive because of the inability to distinguish the effect of sex hormone and growth hormone 
on the sex-specific gene expression. Several methods are possible solutions. One alternative 
 option is to culture hepatic cells in vitro and assess the constitutive gene expression. After 
culturing in hormone-devoid medium environment, the effect of sex hormone on RNA level 
would be eliminated or reduced, leaving the genetic reasons for sex specific gene expression to 
be detected. Mouse with ovaries or testes removed would be an in vivo model to eliminate the 
sex hormone effect on gene expression. The organ removed animals can create similar hormone-
devoid inner environment, leaving the genetic reasons regulating sex specific gene expression to 
be controlled.  
Up to now, no study has assessed how the global gene expression differs in females in 
different estrous cycle status in any somatic tissue, nor did any study assess the gene expression 
on synchronized females. It is known that the estrous cycle in females can influence the 
expression of many genes in the liver, especially the genes that are involved in steroid hormone 
metabolism (100; 101). The discovery that the female eQTLs appear to regulate the expression 
of fewer genes are indications that female gene expression regulation may be more complexly 
regulated, with estrous cycle and hormone fluctuation being possible reasons. A further analysis 
on gene expression in different estrous cycle would further our understanding of genetic 
regulation.  
In summary, this study provided more evidence on the sexually dimorphic genetic 
regulation of gene expression in the mouse liver. Studies on mouse models could be the 
foundation of our understanding of genetically diverse human population, in which huge 
differences exist between men and women with regard to disease susceptibility, drug metabolism 
and xenobiotic response. Although not conclusive, this study pointed to the sex specific gene 
expression regulatory network in mice. Further studies will be needed for further elucidation of 
the effect of sex as contributors to liver biology.   
 35
 Table 1. Distribution of genes that are differently expressed in males and females, 
separated by fold change (p<0.01, Bonferroni correction) 
Fold change Dimorphic genes Female high Male high 
>1 1534 639 895 
>1.2 1394 562 832 
>1.5 549 175 374 
>2.0 183 48 135 
>3 24 12 10 
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 Table 2: The significant sexually dimorphic KEGG pathways discovered by an array 
permutation based method “SAFE”.  
KEGG Size 
Empirical 
p-value 
Adjusted 
p-value Description 
KEGG:00630 14 0 0.017 Glyoxylate and dicarboxylate metabolism
KEGG:00830 54 0 0.017 Retinol metabolism 
KEGG:00982 66 0 0.022 Drug metabolism - cytochrome P450 
KEGG:00150 37 0.001 0.034 Androgen and estrogen metabolism 
KEGG:00590 66 0.001 0.041 Arachidonic acid metabolism 
KEGG:00480 40 0.002 0.045 Glutathione metabolism 
KEGG: 00564 59 0.003 0.048 Glycerophospholipid metabolism 
KEGG:04512 89 0.002 0.049 ECM-receptor interaction 
KEGG:00980 58 0.004 0.049 
Metabolism of xenobiotics by 
cytochrome P450 
 
 
 
 
 
 
 
 
 
 37
 Table 3:  Distribution of QTLs for each sex at different FDR level.  
FDR  Cis-QTL Trans-QTL Total QTL in both sexes 
 Female 815 855 1670 
0.25 Male 719 780 1499 2465 
 Shared 533 111 644  
 Female 632 276 908 
0.05 Male 547 274 821 1402 
 Shared 414 81 495  
 Female 493 165 658 
0.01 Male 430 179 609 1091 
 Shared 325 64 389 
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 Table 4: The SNPs which show the highest LOD score for more than 10 transcripts  
(* indicates same SNP marker in males and females) 
Females    Males    
SNPs Chr 
Genomic 
location 
(Mb) 
Number 
of 
transcripts SNPs Chr 
Genomic 
location 
(Mb) 
Number 
of 
transcripts
rs8256197* 1 130.4166 22 rs8256197* 1 130.4166 15 
UT_2_119.151187* 2 315.6424 13 UT_2_119.151187* 2 315.6424 16 
rs13477796 4 617.4422 12 rs13479126 7 1006.577 24 
rs6258088 4 621.0064 16 rs3675839 7 1010.672 11 
rs6404906 4 672.1987 14 rs6295100 7 1011.097 58 
rs13478831 6 922.0632 28 rs4226520 7 1024.968 11 
rs13481087 11 1596.074 11 rs13479813 8 1211.448 13 
rs13481620* 12 1751.888 26 rs13481620* 12 1751.888 68 
rs8273308* 12 1753.25 23 rs8273308* 12 1753.25 22 
rs13482947 17 2246.618 16     
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 Table 5(a). Confirmed female biased genes. Genes that showed to be more than 2 fold 
higher expressed in females than in males in at least two previous studies, as well as in this 
current study. (GO: Gene Ontology)  
Gene 
Symbol Chromosome Description GO Biological Process 
Abcd2 15 ATP-binding cassette, subfamily D2 Transport 
Acot3 12 AcyI-CoA thioesterase 3 AcyI-CoA metabolism 
Akr l b7 6 Aldo-keto reductase 1 B7 Cellular lipid metabolism
BCO 
14805 19 cDNA sequence BC014805 Transport 
BC089597 10 cDNA sequence BC089597 Metabolism 
Ccnd 1 7 Cyclin D1 Regulation of cell cycle 
Cyp2b 10 7 Cytochrome P450 2b10 Electron transport 
Cyp2b 13 7 Cytochrome P450 2bl 3 Electron transport 
Cyp2b9 7 Cytochrome P450 2b9 Electron transport 
Cyp3a 16 5 Cytochrome Electron transport 
Cyp4a 10 4 Cytochrome Electron transport 
Cyp4 a 14 4 Cytochrome P450 4a14 Electron transport 
Fmo3 1 Flavin-containing monooxygenase 3 Electron transport 
Hao3 3 Hydroxyacid oxidase 3 Electron transport 
Hexb 13 Hexosaminidase B 
Calcium ion 
homeostasis 
Mind2 5 
Monocyte to macrophage differentiation-
associated 2 Cytolysis 
Npall 5 Nicotinamide N-methyhransferase 
Prlr 15 Prolactin receptor Nucleotide catabolism 
Prom 1 5 Prominin 1 Steroid biosynthesis 
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 Rtn4 11 Reticulon 4 
Regulation of cell 
migration 
Serpinb 1 
a 13 Serine (or cysteine) peptidase inhibitor 
Regulation of protein 
catabolism 
Slco 1 a4 6 Solute carrier family, member la4 Organic anion transport 
Sult2a2 7 Sulfotransferase family 2A2 Steroid metabolism 
Sult3a 1 10 Sulfotransferase family 3A1 
Tox 4 
Thymocyte selection-associated HMG 
box gene 
Regulation of 
transcription 
Vldlr 19 Very-low-density lipoprotein receptor Lipid metabolism 
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Table 5(b) Confirmed male biased genes.  Genes that showed to be more than 2 fold higher 
expressed in males than in females in at least two previous studies, as well as in this current 
study. 
Symbol Chromosome Description Biological Process 
2810439FO2Rik 18 RIKEN cDNA 2810439F02 gene  
Abcg2 6 ATP-binding cassette, subfamily G2 Transport 
Cml4 6 Canello-like 4 
Negative regulation of cell 
adhesion 
Cyp4a 12 4 Cytochrome P450, 4a12 Electron transport 
Ddx3y Y DEAD (Asp-Glu-Ala-Asp) box polypeptide 3 
Egfr 11 Epidermal growth factor receptor Signal transduction 
Eif2s3y Y 
Eukaryotic translation initiation factor 
2, subunit 3 Protein biosynthesis 
Elovl3 19 
Elongation of very-long-chain fatty 
acids-like 3 Fatty-acid biosynthesis 
Gstp1 19 Glutathione S-transferase, pi 1 Glutathione metabolism 
Hsd3b5 3 Hydroxysteroid dehydrogenase-5 Steroid biosynthesis 
Jaridld Y 
Jumonji, AT-rich interactive domain 
1D Regulation of transcription 
Nudt7 8 Major urinary protein 4 Coenzyme A catabolism 
Omd 13 Osteomodulin Cell adhesion 
Scara5 14 Scavenger receptor class A5  
Slco 1 a1 6 Solute carrier transpoter family 1a Organic anion transport 
Susd4 1 Sushi domain containing 4  
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Figure 1. Sex-specific transcriptome maps reveal differences and similarities in the genetic 
regulation of gene expression in mouse liver. The female (A) and male (B) transcriptome maps 
are shown. Genomic location of each SNP marker (horizontal axis) and each transcript (vertical 
axis) are plotted. Each cross represents the location of the maximum QTL for a particular gene. 
Locally regulated (cis-eQTL) genes are located along the 45 degree lines while the vertical lines 
correspond to the loci which regulate distant (trans-eQTL) genes. The color of each symbol 
corresponds to the significance of the QTL (color bar). (C, D) Histogram counts of the number of 
transcripts regulated at each SNP marker. 
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Figure 2. Master regulator loci in female (A) and male (B) mouse liver. (A) Chromosome 6 
contains a female-specific QTL hotspot, with 28 transcripts regulated by this locus (FDR <= 0.25, 
average LOD score = 4.98). The positive additive coefficient (slim green line) indicates that 
DBA2J increases the trait value. Identical-by-descent regions between DBA/2J and C57BL/6J 
strains are shaded in gray. The top panel shows annotated genes located in the QTL region. 
Genes which have non-synonymous coding SNPs are labeled in blue, local-regulated genes in 
italics and trans-regulated genes in plain text. The gray location markers indicate that the gene 
was not represented on the array. The pink and the gray lines represent the significant and 
suggestive threshold, which are generated by permutation tests. (B) A region on chromosome 7 
contains a male-specific QTL hotspot, with 55 transcripts regulated by this locus (FDR <= 0.25, 
average LOD score 5.05). The negative additive coefficient (the slim red line) indicates that 
C57B6J increases the trait value.   
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Figure 3. Co-correlation analysis of gene expression reveals sex-specific ‘cliques.’ Genes 
with high ( ׀rpearson ׀>0.9) correlation in female (A-C) and male (D-F) liver transcriptome were 
selected. (A, D) Clustering of transcripts based on Pearson correlation coefficients. (B, E) Two 
dimensional hierarchical clustering of the expression of the highly correlated genes in each 
strain/sex. The genes were shown in the same order along the vertical axis as in A and D. (C, F) 
Hierarchical clustering diagram of the genetic control of gene expression of the highly correlated 
genes in each strain/sex. Genetic loci associated with gene expression phenotypes with small p-
values were mapped onto the mouse genome. 
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Figure 4: The top functional networks (Ingenuity®) identified for the highly correlated genes 
represented by the blue bars in figure 3. (A) The top network (“Cell-cell signaling and 
interaction”) identified in female mice, with an ingenuity score of 36. (B) The top network 
(“Molecular transport”) identified in male mice, with an ingenuity score of 42. The genes in blue 
are in the set of highly correlated genes and genes in plain color are curated by Ingenuity to form 
a network. Yellow lines indicate direct interactions. Ellipse, square, triangle, trapezoikd, lozenge 
and circle represent transcription regulator, cytokine, kinase, transporter, enzyme and other 
molecules, respectively.  
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